by CU Cancer Center | Jan 3, 2019 | C3 Magazine, Featured, Patient Care
At 32 years old and 33 weeks pregnant, Emily Daniels lived the kind of life that many of us strive to achieve. With a baby boy on the way, a loving husband, a healthy and happy 3-year-old daughter, family and friends close by, a good job, and an active social life,...
by Garth Sundem | Dec 31, 2018 | Featured, Latest News, Research
According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between the years 1995 and 2001 had 15 percent chance of being alive 5 years later. For patients with stage IV disease, describing cancer that has spread to distant...
by Garth Sundem | Nov 8, 2018 | Featured, Latest News, Research
The HER2 gene is a well-known driver of breast cancer, where changes in this gene are found in about 1-in-5 cases of the disease. HER2 also contributes to about 3 percent of lung cancers, representing about 6,500 patients per year. But while drugs like trastuzumab and...
by Garth Sundem | Sep 25, 2018 | Featured, Latest News, Research
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World...
by Garth Sundem | Sep 24, 2018 | Featured, Latest News, Research
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer (NSCLC) presented on the press program of the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer show a...
